Cargando…
Myocardial infarction models in NOD/Scid mice for cell therapy research: permanent ischemia vs ischemia–reperfusion
Myocardial infarction animal studies are used to study disease mechanisms and new treatment options. Typically, myocardial infarction (MI) is induced by permanent occlusion of the left anterior descending artery. Since in MI patients coronary blood flow is often restored new experimental models bett...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498004/ https://www.ncbi.nlm.nih.gov/pubmed/26185738 http://dx.doi.org/10.1186/s40064-015-1128-y |
_version_ | 1782380562683527168 |
---|---|
author | van Zuylen, Vanessa-Leigh den Haan, Melina C Roelofs, Helene Fibbe, Willem E Schalij, Martin J Atsma, Douwe E |
author_facet | van Zuylen, Vanessa-Leigh den Haan, Melina C Roelofs, Helene Fibbe, Willem E Schalij, Martin J Atsma, Douwe E |
author_sort | van Zuylen, Vanessa-Leigh |
collection | PubMed |
description | Myocardial infarction animal studies are used to study disease mechanisms and new treatment options. Typically, myocardial infarction (MI) is induced by permanent occlusion of the left anterior descending artery. Since in MI patients coronary blood flow is often restored new experimental models better reflecting clinical practice are needed. Here, permanent ischemia MI (PI group) was compared with transient ischemia (45 min) (IR group) in immunodeficient NOD/Scid mice. Cardiac function, infarct size, wall thickness and total collagen deposition were significantly reduced only in PI mice. Cardiac inflammatory cells and serum cytokine levels were less dynamic in IR animals compared to PI. So although IR better reflects clinical practice, it is secondary to PI for investigating cell therapy, since it induces too little damage to provide a measurable therapeutic window. MI did result in significant changes in the inflammatory state, indicating this immunodeficient mouse strain is valuable to study human cell therapy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40064-015-1128-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4498004 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-44980042015-07-16 Myocardial infarction models in NOD/Scid mice for cell therapy research: permanent ischemia vs ischemia–reperfusion van Zuylen, Vanessa-Leigh den Haan, Melina C Roelofs, Helene Fibbe, Willem E Schalij, Martin J Atsma, Douwe E Springerplus Research Myocardial infarction animal studies are used to study disease mechanisms and new treatment options. Typically, myocardial infarction (MI) is induced by permanent occlusion of the left anterior descending artery. Since in MI patients coronary blood flow is often restored new experimental models better reflecting clinical practice are needed. Here, permanent ischemia MI (PI group) was compared with transient ischemia (45 min) (IR group) in immunodeficient NOD/Scid mice. Cardiac function, infarct size, wall thickness and total collagen deposition were significantly reduced only in PI mice. Cardiac inflammatory cells and serum cytokine levels were less dynamic in IR animals compared to PI. So although IR better reflects clinical practice, it is secondary to PI for investigating cell therapy, since it induces too little damage to provide a measurable therapeutic window. MI did result in significant changes in the inflammatory state, indicating this immunodeficient mouse strain is valuable to study human cell therapy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40064-015-1128-y) contains supplementary material, which is available to authorized users. Springer International Publishing 2015-07-10 /pmc/articles/PMC4498004/ /pubmed/26185738 http://dx.doi.org/10.1186/s40064-015-1128-y Text en © van Zuylen et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Research van Zuylen, Vanessa-Leigh den Haan, Melina C Roelofs, Helene Fibbe, Willem E Schalij, Martin J Atsma, Douwe E Myocardial infarction models in NOD/Scid mice for cell therapy research: permanent ischemia vs ischemia–reperfusion |
title | Myocardial infarction models in NOD/Scid mice for cell therapy research: permanent ischemia vs ischemia–reperfusion |
title_full | Myocardial infarction models in NOD/Scid mice for cell therapy research: permanent ischemia vs ischemia–reperfusion |
title_fullStr | Myocardial infarction models in NOD/Scid mice for cell therapy research: permanent ischemia vs ischemia–reperfusion |
title_full_unstemmed | Myocardial infarction models in NOD/Scid mice for cell therapy research: permanent ischemia vs ischemia–reperfusion |
title_short | Myocardial infarction models in NOD/Scid mice for cell therapy research: permanent ischemia vs ischemia–reperfusion |
title_sort | myocardial infarction models in nod/scid mice for cell therapy research: permanent ischemia vs ischemia–reperfusion |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498004/ https://www.ncbi.nlm.nih.gov/pubmed/26185738 http://dx.doi.org/10.1186/s40064-015-1128-y |
work_keys_str_mv | AT vanzuylenvanessaleigh myocardialinfarctionmodelsinnodscidmiceforcelltherapyresearchpermanentischemiavsischemiareperfusion AT denhaanmelinac myocardialinfarctionmodelsinnodscidmiceforcelltherapyresearchpermanentischemiavsischemiareperfusion AT roelofshelene myocardialinfarctionmodelsinnodscidmiceforcelltherapyresearchpermanentischemiavsischemiareperfusion AT fibbewilleme myocardialinfarctionmodelsinnodscidmiceforcelltherapyresearchpermanentischemiavsischemiareperfusion AT schalijmartinj myocardialinfarctionmodelsinnodscidmiceforcelltherapyresearchpermanentischemiavsischemiareperfusion AT atsmadouwee myocardialinfarctionmodelsinnodscidmiceforcelltherapyresearchpermanentischemiavsischemiareperfusion |